Cameroon's MDR-TB treatment programme jeopardised by cross-border migration
Authors:
Open Access
- 31 January 2016
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 47 (2) , 684-686
Abstract
MDR-TB treatment programme can be jeopardised by cross-border migration as seen in Cameroon http://ow.ly/WHbxwKeywords
This publication has 8 references indexed in Scilit:
- High effectiveness of a 12-month regimen for MDR-TB patients in CameroonThe International Journal of Tuberculosis and Lung Disease, 2015
- Towards tuberculosis elimination: an action framework for low-incidence countriesEuropean Respiratory Journal, 2015
- Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultationEuropean Respiratory Journal, 2014
- Tuberculosis elimination: theory and practice in EuropeEuropean Respiratory Journal, 2014
- A poor drug-resistant tuberculosis programme is worse than no programme: time for a change [Perspective]The International Journal of Tuberculosis and Lung Disease, 2013
- Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomesEuropean Respiratory Journal, 2012
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateEuropean Respiratory Journal, 2011
- Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2010